Shirofune Integration with LeadRebel

Shirofune has established itself as a premier marketing analytics software in Japan, boasting a remarkable 91% market share. Corporations like Dentsu and Rakuten trust Shirofune to power their advertising campaigns, ensuring that their strategies are not only efficient but also yield measurable results. By utilizing Shirofune, businesses can easily track and analyze their ad performance, thus enhancing their advertising strategies significantly. The Shirofune integration with LeadRebel brings added layers to your marketing efforts. LeadRebel allows you to identify undisclosed website visitors, enriching the data available via Shirofune. This integration provides actionable insights into visitor behavior and ad effectiveness, helping organizations like Dentsu and Rakuten make data-driven decisions to refine their campaigns. Moreover, this integration easily connects with popular CRM systems and various marketing tools, allowing advertisers to centralize their efforts. For instance, by syncing data between Shirofune and a CRM, like Salesforce, companies can track customer interactions from initial ad exposure through to conversion, paving the way for smarter follow-ups. The Shirofune integration not only increases operational efficiency but also simplifies marketing workflows. By using automated processes to funnel leads identified by LeadRebel into your existing systems, your team can focus on strategy rather than manual data management. This combination creates an effective loop of data and insights that substantiates your advertising efforts. Integration can be executed natively, through the LeadRebel API, or via Zapier. This flexibility ensures that you can implement the solution that best fits your organization’s needs.

LeadRebel® is a software for B2B lead generation. We show you which companies and persons visited your website, provide detailed information about them and enable you to push them into CRM or marketing/sales software of your choice. Get real-time, high-intent leads now!